Ketamine analgesia, NMDA receptors and the gates of perception.
Oye
I
I
D000700:Analgesics / Q000378:metabolism / Q000627:therapeutic use*; D001161:Arteriosclerosis / Q000503:physiopathology; D002908:Chronic Disease; D018691:Excitatory Amino Acid Antagonists / Q000378:metabolism / Q000627:therapeutic use*; D006801:Humans; D015640:Ion Channel Gating / Q000187:drug effects; D007511:Ischemia / Q000503:physiopathology; D007649:Ketamine / Q000378:metabolism / Q000627:therapeutic use*; D007866:Leg / Q000098:blood supply; D010146:Pain / Q000188:drug therapy / Q000503:physiopathology; D010465:Perception / Q000187:drug effects*; D010622:Phencyclidine / Q000378:metabolism; D016194:Receptors, N-Methyl-D-Aspartate / Q000037:antagonists & inhibitors* / Q000378:metabolism / Q000502:physiology; D012677:Sensation / Q000187:drug effects
D000700:Analgesics; D018691:Excitatory Amino Acid Antagonists; D016194:Receptors, N-Methyl-D-Aspartate; D007649:Ketamine; D010622:Phencyclidine